Lacktman Comments on Approval of Telehealth Relationship Between Hospital, Clinic
04 June 2018
Partner Nate Lacktman was quoted in a FierceHealthcare article, “OIG Approves Telehealth Purchasing Arrangement that Would Support HIV Care,” about the Department of Health and Human Services’ approval of a hospital’s request to buy a laptop, webcam, microphone and video conferencing software for a county-run clinic to provide free HIV prevention consultations.
Lacktman said the OIG advisory aligns with a 2011 opinion in which the agency allowed a health system to provide community hospitals with free telemedicine technology as part of a telestroke arrangement, though he noted that the OIG might have felt differently if the request had involved a mail-order pharmacy that delivered medications directly to patients’ homes.
Lacktman said the OIG advisory aligns with a 2011 opinion in which the agency allowed a health system to provide community hospitals with free telemedicine technology as part of a telestroke arrangement, though he noted that the OIG might have felt differently if the request had involved a mail-order pharmacy that delivered medications directly to patients’ homes.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”